Vice President, Molecular Diagnostics Autonomous Medical Device Incorporated Santa Ana, California, United States
Autonomous Medical Devices Incorporated (AMDI) has developed a compact, easy to use molecular point-of-care system that utilizes multiplexing capability specifically for CLIA-Waived Environments. This ultrafast RT-PCR system leverages Autolab HBH technology to overcome unacceptable tradeoffs of time, technical complexity, quality, and cost of current sample preparation methods necessary for molecular testing. This technology allows AMDI’s Fast PCR to not only be scalable up to 32 targets per sample, but to do so in less than 10 minutes while retaining the gold standard RT-PCR sensitivity and specificity.
